PART I : Overview: We are a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Our beta islet, T cell and NK cell programs are allogeneic, meaning they are derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. As a result, we...
Q2 FY2026 — expected 2026-08-18
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2025-12-31 | 0001104659-26-026759 | EDGAR | 100K words |
| 2025-03-19 | 2024-12-31 | 0001558370-25-003299 | EDGAR | — |
| 2024-03-14 | 2023-12-31 | 0001558370-24-003165 | EDGAR | — |
| 2023-03-16 | 2022-12-31 | 0001558370-23-003962 | EDGAR | — |
| 2022-03-17 | 2021-12-31 | 0001558370-22-003867 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001104659-25-110851 | EDGAR | 27K words |
| 2025-08-14 | 2025-06-30 | 0001558370-25-011575 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0001558370-25-007885 | EDGAR | — |
| 2024-11-05 | 2024-09-30 | 0001558370-24-014345 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001558370-24-011467 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001558370-24-007469 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001558370-23-018408 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001558370-23-014082 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001558370-23-009262 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001558370-22-017287 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0001558370-22-013181 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001558370-22-008860 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-26 | 0001104659-26-035256 | EDGAR | 1K words |
| 2026-03-12 | 0001104659-26-026761 | EDGAR | — |
| 2026-01-23 | 0001104659-26-006236 | EDGAR | — |
| 2026-01-12 | 0001104659-26-002748 | EDGAR | — |
| 2026-01-08 | 0001104659-26-001952 | EDGAR | — |
| 2025-12-29 | 0001104659-25-124836 | EDGAR | — |
| 2025-12-12 | 0001104659-25-120654 | EDGAR | — |
| 2025-12-09 | 0001104659-25-119494 | EDGAR | — |
| 2025-11-13 | 0001104659-25-110862 | EDGAR | — |
| 2025-08-29 | 0001104659-25-085658 | EDGAR | — |
103 total filings indexed. 76 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001850119 |
| Ticker | IPSC |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.centurytx.com |
| Listed | 2021-06-18 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/IPSC (~200 tokens, structured JSON with cryptographic provenance)